Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: J Virol Methods. 2009 Sep 1;162(1-2):218–222. doi: 10.1016/j.jviromet.2009.08.013

Table 1. Within-run precision studies using patient samples from East Africa, Abbott m2000rt RealTime™ HIV-1 assay with manual sample preparation compared with the ROCHE COBAS® AmpliPrep™/AMPLICOR™ HIV-1 MONITOR® v1.5a.

Sample run number ROCHE COBAS® AMPLICOR™ HIV-1 MONITOR® v1.5 Abbott m2000rt RealTime™ HIV-1
1 (n=10)
Mean 5.51 5.07
Range (low, high) (5.43, 5.55) (4.84, 5.22)
SD (manufacturer's claim)b 0.04 (0.1) 0.12 (0.04)
CV 0.71% 2.27%
2 (n=10)
Mean 4.32 4.20
Range (4.19, 4.38) (4.16, 4.24)
SD (manufacturer's claim)b 0.08 (0.14) 0.03 (0.02)
CV 1.76% 0.66%
3 (n=10)
Mean 3.07 3.29
Range (2.92, 3.31) (3.15, 3.36)
SD (manufacturer's claim)b 0.13 (0.17) 0.06 (0.05)
CV 4.31% 1.85%
a

Log transformed HIV-1 RNA values are reported

b

Standard deviation (manufacturer's claims for total assay variability)